RAR is particularly valuable in epidemiology because it has the potential to enhance the ethical aspects and efficiency of clinical trials. By favoring more effective treatments as the trial progresses, it minimizes the number of patients exposed to inferior treatments. This approach is highly relevant in the context of emerging infectious diseases, where rapid identification of effective treatments can significantly impact public health.
